PetIQ (PETQ) plans to raise $86 million in an IPO on Friday, July 21st, IPO Scoop reports. The company will be issuing 5,700,000 shares at a price of $14.00-$16.00 per share.

In the last year, PetIQ generated $214.9 million in revenue and $1.2 million in net income. PetIQ has a market-cap of $301.5 million.

Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ provided the following description of their company for its IPO: “PetIQ is a rapidly growing distributor and manufacturer of veterinarian-grade pet Rx medications, OTC flea and tick preventatives and health and wellness products for dogs and cats. We pioneered and are the leading seller to the retail channel of pet products that were previously available for purchase primarily from veterinary clinics. We enable our customers to offer pet owners choice, affordability and convenience on products from leading national brands as well as our proprietary value-branded alternatives. “.

PetIQ was founded in 2016 and has 202 employees. The company is located at 500 E. Shore Dr., Suite 120, Eagle, ID 83616, US and can be reached via phone at 208-939-8900 or on the web at http://www.petiq.com.

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with Analyst Ratings Network's FREE daily email newsletter.